FIGURE 2 | Modern Pathology

FIGURE 2

From: Loss of p53 and c-myc Overrepresentation in Stage T2-3N1-3M0 Prostate Cancer are Potential Markers for Cancer Progression

FIGURE 2

Comparison of the most common FISH anomalies between case and control groups in Stage T2–3N1–3M0 primary prostate cancers. P values have been calculated for all markers, comparing 26 patients in the case group with 26 patients in the control group for LPL, CEP8, and c-myc. Because there was not enough tissue for FISH analysis, 22 patients in the case group and 22 patients in the control group were evaluated for CEP7 and 7q31, and 25 patients in the case group and 25 patients in the control group were evaluated for CEP17 and p53.

Back to article page